For these patients at risk, updated 2018 AHA/ACC treatment guidelines recommend

70 mg/dL as the new threshold to trigger action2

Dan, youth soccer coach*

History of PAD

History of PAD

Clinical CVD Diagnosis

Peripheral artery disease—
calf claudication with exertion


LDL-C Level

115 mg/dL

Current Lipid-
Lowering Therapy

Atorvastatin: 20 mg/day
with inability to tolerate
high-intensity statins

On other cardiovascular medications
as per recent guidance recommendations.

When will the next CV event strike a patient with PAD in your practice?

Clinical Challenges in Established Cardiovascular Disease: Symptomatic PAD

Watch a physician-patient scenario featuring Dr. Michael Davidson and a patient with peripheral artery disease.

*Real-world clinical profile of patient experience with Repatha®. Hypothetical name, occupation, and photography used.

AHA/ACC = American Heart Association/American College of Cardiology; CV = cardiovascular; CVD = cardiovascular disease; LDL-C = low-density lipoprotein cholesterol; MI = myocardial infarction; PAD = peripheral artery disease.